ECMO in cardiac arrest and cardiogenic shock.

Authors:
Napp LC; Kühn C; Bauersachs J.

Journal:
Herz

Publication Year: 2017

DOI:
10.1007/s00059-016-4523-4

PMCID:
PMC5306351

PMID:
28127638

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Herz

Abbreviation: Herz

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Increased cardiovascular risk in patients with chronic kidney disease.
Vondenhoff S; Schunk SJ; Noels H. (2024) - Transparency Score: 3/6
Accuracy of VO<sub>2</sub> estimation according to the widely used Krakau formula for the predictio…
Reiter T; Kerzner J; Fette G and 7 more (2023) - Transparency Score: 3/6
A practical approach for the treatment of post-COVID symptoms.
Heitmann J; Kreutz J; Aldudak S and 3 more (2023) - Transparency Score: 2/6
Cardiac surgery during the COVID-19 pandemic.
Moosdorf R. (2023) - Transparency Score: 2/6
Effects of hydroxychloroquine on atrial electrophysiology in in silico wild-type and PITX2<sup>+/-<…
Song E. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest L. C. Napp received travel support outside this work from Abbott, Abiomed, Bayer, Biotronik, Boston Scientific, Cordis, Lilly, Medtronic, Pfizer, Servier and Volcano, and lecture honoraria from Maquet. C. Kühn received lecture honoraria from Maquet and J. Bauersachs received lecture honoraria from Abiomed. This article does not contain any studies with human participants or animals performed by any of the authors."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025